Assessment and management of febrile neutropenia in emergency departments within a regional health authority-a benchmark analysis

被引:0
作者
Szwajcer, D. [1 ,2 ]
Czaykowski, P. [1 ,2 ]
Turner, D. [2 ]
机构
[1] Univ Manitoba, Dept Med Oncol & Haematol, Winnipeg, MB, Canada
[2] CancerCare Manitoba, Winnipeg, MB, Canada
关键词
Antineoplastic chemotherapy; febrile neutropenia; emergency department; ACUTE MYOCARDIAL-INFARCTION; CANCER; GUIDELINES; CARE;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives Febrile neutropenia is considered an oncologic emergency, for which prompt initiation of antibiotics is essential. Methods We conducted a retrospective cohort study for the 2006 calendar year involving all adult oncology patients presenting with febrile neutropenia to a regional health authority's emergency departments. The objective was to determine the time from triage to antibiotic administration and its impact on patient outcomes. Results We identified 68 patients presenting with febrile neutropenia, most of whom (76%) were seen in tertiary care centers. Of those patients, 65% were triaged to be seen within 15 minutes of arrival in the emergency room; however, the median time to reassessment was 57 minutes. The median time from triage to antibiotic administration was 5 hours (range: 1.23-22.8 hours). No increased risk of death or increased length of hospital stay was associated with delayed antibiotic administration. Older patients and patients without caregiver support were more likely to experience delayed antibiotic administration (odds ratio: 3.8 and 12.7 respectively). Conclusions We were not able to show a deleterious effect of delay in antibiotic administration, but our analysis identified several points at which patient flow through the emergency room could be improved.
引用
收藏
页码:280 / 284
页数:5
相关论文
共 19 条
[1]  
Baltic Tammy, 2002, Clin J Oncol Nurs, V6, P337, DOI 10.1188/02.CJON.337-340
[2]  
Beveridge R, 1998, J Emerg Med, V16, P507
[3]   QUANTITATIVE RELATIONSHIPS BETWEEN CIRCULATING LEUKOCYTES AND INFECTION IN PATIENTS WITH ACUTE LEUKEMIA [J].
BODEY, GP ;
BUCKLEY, M ;
SATHE, YS ;
FREIREICH, EJ .
ANNALS OF INTERNAL MEDICINE, 1966, 64 (02) :328-+
[4]  
BOW EJ, 2005, GUIDELINES MANAGEMEN
[5]   Hospital quality for acute myocardial infarction - Correlation among process measures and relationship with short-term mortality [J].
Bradley, Elizabeth H. ;
Herrin, Jeph ;
Elbel, Brian ;
McNamara, Robert L. ;
Magid, David J. ;
Nallamothu, Brahmajee K. ;
Wang, Yongfei ;
Normand, Sharon-Lise T. ;
Spertus, John A. ;
Krumholz, Harlan M. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (01) :72-78
[6]  
Cordonnier C, 2005, HAEMATOLOGICA, V90, P1102
[7]  
CRONIN G, 2006, BALANCED SCORE CARDC
[8]   2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer [J].
Hughes, WT ;
Armstrong, D ;
Bodey, GP ;
Bow, EJ ;
Brown, AE ;
Calandra, T ;
Feld, R ;
Pizzo, PA ;
Rolston, KVI ;
Shenep, JL ;
Young, LS .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (06) :730-751
[9]   NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].
KAPLAN, EL ;
MEIER, P .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481
[10]   The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients [J].
Klastersky, J ;
Paesmans, M ;
Rubenstein, EB ;
Boyer, M ;
Elting, L ;
Feld, R ;
Gallagher, J ;
Herrstedt, J ;
Rapoport, B ;
Rolston, K ;
Talcott, J .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (16) :3038-3051